606 related articles for article (PubMed ID: 28081459)
1. Targeted delivery of in situ PCR-amplified Sleeping Beauty transposon genes to cancer cells with lipid-based nanoparticle-like protocells.
Ma K; Fu D; Yu D; Cui C; Wang L; Guo Z; Mao C
Biomaterials; 2017 Mar; 121():55-63. PubMed ID: 28081459
[TBL] [Abstract][Full Text] [Related]
2. Counterselection and co-delivery of transposon and transposase functions for Sleeping Beauty-mediated transposition in cultured mammalian cells.
Converse AD; Belur LR; Gori JL; Liu G; Amaya F; Aguilar-Cordova E; Hackett PB; McIvor RS
Biosci Rep; 2004 Dec; 24(6):577-94. PubMed ID: 16158196
[TBL] [Abstract][Full Text] [Related]
3. Integration and long-term expression in xenografted human glioblastoma cells using a plasmid-based transposon system.
Ohlfest JR; Lobitz PD; Perkinson SG; Largaespada DA
Mol Ther; 2004 Aug; 10(2):260-8. PubMed ID: 15294173
[TBL] [Abstract][Full Text] [Related]
4. Identification of Sleeping Beauty transposon insertions in solid tumors using linker-mediated PCR.
Janik CL; Starr TK
J Vis Exp; 2013 Feb; (72):e50156. PubMed ID: 23407503
[TBL] [Abstract][Full Text] [Related]
5. Endothelial targeting of the Sleeping Beauty transposon within lung.
Liu L; Sanz S; Heggestad AD; Antharam V; Notterpek L; Fletcher BS
Mol Ther; 2004 Jul; 10(1):97-105. PubMed ID: 15233946
[TBL] [Abstract][Full Text] [Related]
6. Sleeping Beauty-baculovirus hybrid vectors for long-term gene expression in the eye.
Turunen TA; Laakkonen JP; Alasaarela L; Airenne KJ; Ylä-Herttuala S
J Gene Med; 2014; 16(1-2):40-53. PubMed ID: 24464652
[TBL] [Abstract][Full Text] [Related]
7. Functionalized PDA/DEX-PEI@HA nanoparticles combined with sleeping-beauty transposons for multistage targeted delivery of CRISPR/Cas9 gene.
Ma K; Li W; Zhu G; Sun S; Chi H; Yin Y; Diao H; Xing XJ; Guo Z; Wang L; Xu W; Cui C; Xu J
Biomed Pharmacother; 2021 Oct; 142():112061. PubMed ID: 34449313
[TBL] [Abstract][Full Text] [Related]
8. Construction and Quantitative Evaluation of a Tissue-Specific Sleeping Beauty by EDL2-Specific Transposase Expression in Esophageal Squamous Carcinoma Cell Line KYSE-30.
Mahmoudian RA; Fathi F; Farshchian M; Abbaszadegan MR
Mol Biotechnol; 2023 Mar; 65(3):350-360. PubMed ID: 35474410
[TBL] [Abstract][Full Text] [Related]
9. Helper-Independent Sleeping Beauty transposon-transposase vectors for efficient nonviral gene delivery and persistent gene expression in vivo.
Mikkelsen JG; Yant SR; Meuse L; Huang Z; Xu H; Kay MA
Mol Ther; 2003 Oct; 8(4):654-65. PubMed ID: 14529839
[TBL] [Abstract][Full Text] [Related]
10. Gene transfer into genomes of human cells by the sleeping beauty transposon system.
Geurts AM; Yang Y; Clark KJ; Liu G; Cui Z; Dupuy AJ; Bell JB; Largaespada DA; Hackett PB
Mol Ther; 2003 Jul; 8(1):108-17. PubMed ID: 12842434
[TBL] [Abstract][Full Text] [Related]
11. Unexpectedly high copy number of random integration but low frequency of persistent expression of the Sleeping Beauty transposase after trans delivery in primary human T cells.
Huang X; Haley K; Wong M; Guo H; Lu C; Wilber A; Zhou X
Hum Gene Ther; 2010 Nov; 21(11):1577-90. PubMed ID: 20528476
[TBL] [Abstract][Full Text] [Related]
12. Hyperactive transposase mutants of the Sleeping Beauty transposon.
Baus J; Liu L; Heggestad AD; Sanz S; Fletcher BS
Mol Ther; 2005 Dec; 12(6):1148-56. PubMed ID: 16150650
[TBL] [Abstract][Full Text] [Related]
13. Sleeping beauty transposon-mediated gene therapy for prolonged expression.
Hackett PB; Ekker SC; Largaespada DA; McIvor RS
Adv Genet; 2005; 54():189-232. PubMed ID: 16096013
[TBL] [Abstract][Full Text] [Related]
14. Transposon-independent increase of transcription by the Sleeping Beauty transposase.
Masuda K; Yamamoto S; Endoh M; Kaneda Y
Biochem Biophys Res Commun; 2004 May; 317(3):796-800. PubMed ID: 15081410
[TBL] [Abstract][Full Text] [Related]
15. Stable gene transfer and expression in human primary T cells by the Sleeping Beauty transposon system.
Huang X; Wilber AC; Bao L; Tuong D; Tolar J; Orchard PJ; Levine BL; June CH; McIvor RS; Blazar BR; Zhou X
Blood; 2006 Jan; 107(2):483-91. PubMed ID: 16189271
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic correction and long-term expression of factor VIII in hemophilic mice by immunotolerization and nonviral gene transfer using the Sleeping Beauty transposon system.
Ohlfest JR; Frandsen JL; Fritz S; Lobitz PD; Perkinson SG; Clark KJ; Nelsestuen G; Key NS; McIvor RS; Hackett PB; Largaespada DA
Blood; 2005 Apr; 105(7):2691-8. PubMed ID: 15576475
[TBL] [Abstract][Full Text] [Related]
17. RNA as a source of transposase for Sleeping Beauty-mediated gene insertion and expression in somatic cells and tissues.
Wilber A; Frandsen JL; Geurts JL; Largaespada DA; Hackett PB; McIvor RS
Mol Ther; 2006 Mar; 13(3):625-30. PubMed ID: 16368272
[TBL] [Abstract][Full Text] [Related]
18. Gene insertion and long-term expression in lung mediated by the Sleeping Beauty transposon system.
Belur LR; Frandsen JL; Dupuy AJ; Ingbar DH; Largaespada DA; Hackett PB; Scott McIvor R
Mol Ther; 2003 Sep; 8(3):501-7. PubMed ID: 12946324
[TBL] [Abstract][Full Text] [Related]
19. Transposon-based interferon gamma gene transfer overcomes limitations of episomal plasmid for immunogene therapy of glioblastoma.
Wu A; Oh S; Ericson K; Demorest ZL; Vengco I; Gharagozlou S; Chen W; Low WC; Ohlfest JR
Cancer Gene Ther; 2007 Jun; 14(6):550-60. PubMed ID: 17415381
[TBL] [Abstract][Full Text] [Related]
20. Multifunctional disulfide-based cationic dextran conjugates for intravenous gene delivery targeting ovarian cancer cells.
Song Y; Lou B; Zhao P; Lin C
Mol Pharm; 2014 Jul; 11(7):2250-61. PubMed ID: 24892216
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
